Related references
Note: Only part of the references are listed.Inactivation of TLR9 by a Suppressive Oligodeoxynucleotides Can Ameliorate the Clinical Signs of EAN
Yu-Zhong Wang et al.
IMMUNOLOGICAL INVESTIGATIONS (2012)
Expression of Toll-Like Receptors 2, 4 and 9 in Patients with Guillain-Barre Syndrome
Yu-Zhong Wang et al.
NEUROIMMUNOMODULATION (2012)
IVIg Attenuates TLR-9 Activation in B Cells from SLE Patients
Aharon Kessel et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2011)
Toll-like receptor control of glucocorticoid-induced apoptosis in human plasmacytoid predendritic cells (pDCs)
Yves Lepelletier et al.
BLOOD (2010)
Toll-like receptors: a family of innate sensors of danger that alert and drive immunity
M.T. Montero Vega et al.
ALLERGOLOGIA ET IMMUNOPATHOLOGIA (2009)
Type I interferons might form the link between Toll-like receptor (TLR) 3/7 and TLR4-mediated synovial inflammation in rheumatoid arthritis (RA)
M. F. Roelofs et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
Unexpected regulatory roles of TLR4 and TLR9 in experimental autoimmune encephalomyelitis
Monica Marta et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2008)
Glucocorticoids inhibit IRF3 phosphorylation in response to toll-like receptor-3 and-4 by targeting TBK1 activation
Claire E. McCoy et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Increased toll-like receptor (TLR)2 and TLR4 expression in monocytes from patients with type 1 diabetes: Further evidence of a proinflammatory state
Sridevi Devaraj et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Expression of TLR4 and TLR9 mRNA in Lewis rats with experimental allergic neuritis
Yong-Ning Deng et al.
NEUROIMMUNOMODULATION (2008)
Toll-like receptors: key activators of leucocytes and regulator of haematopoiesis
Anne F. McGettrick et al.
BRITISH JOURNAL OF HAEMATOLOGY (2007)
Glucocorticoids and the innate immune system: Crosstalk with the Toll-like receptor signaling network
Yurii Chinenov et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2007)
Macrophage glucocorticoid receptors regulate toll-like receptor 4-mediated inflammatory responses by selective inhibition of p38 MAP kinase
Sandip Bhattacharyya et al.
BLOOD (2007)
TLR2 synergizes with both TLR4 and TLR9 for induction of the MyD88-dependent splenic cytokine and chemokine response to Streptococcus pneumoniae
Katherine S. Lee et al.
CELLULAR IMMUNOLOGY (2007)
Myasthenia gravis: past, present, and future
Bianca M. Conti-Fine et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Glucocorticoids severely impair differentiation and antigen presenting function of dendritic cells despite upregulation of Toll-like receptors
Daniela Rozkova et al.
CLINICAL IMMUNOLOGY (2006)
TLR9/MyD88 signaling is required for class switching to pathogenic IgG2a and 2b autoantibodies in SLE
M Ehlers et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Increased toll-like receptor 4 expression in thymus of myasthenic patients with thymitis and thymic involution
P Bernasconi et al.
AMERICAN JOURNAL OF PATHOLOGY (2005)
Reduction of CpG-induced arthritis by suppressive oligodeoxynucleotides
RA Zeuner et al.
ARTHRITIS AND RHEUMATISM (2002)
Molecular mechanisms of immunomodulatory activity of glucocorticoids
C Riccardi et al.
PHARMACOLOGICAL RESEARCH (2002)
Tissue expression of human toll-like receptors and differential regulation of toll-like receptor mRNAs in leukocytes in response to microbes, their products, and cytokines
KA Zarember et al.
JOURNAL OF IMMUNOLOGY (2002)
Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies
W Hoch et al.
NATURE MEDICINE (2001)
Toll-like receptor family and signalling pathway
M Muzio et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2000)
Myasthenia gravis - Recommendations for clinical research standards
A Jaretzki et al.
NEUROLOGY (2000)
Validity and reliability of two muscle strength scores commonly used as endpoints in assessing treatment of myasthenia gravis
T Sharshar et al.
JOURNAL OF NEUROLOGY (2000)
Share Paper
